Navigation Links
SemBioSys receives milestone payments from AVAC Ltd.
Date:4/7/2008

Canadian Biotechnology Company receives payments for achieving milestones

with safflower-produced insulin and Botaneco subsidiary

TSX symbol: SBS

CALGARY, April 7 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced that it has received milestone payments totaling CDN$850,000 from AVAC Ltd. The payments relate to separate agreements that SemBioSys has entered into with AVAC to advance the development of its safflower-produced insulin and the commercial activities of its wholly-owned subsidiary, Botaneco Specialty Ingredients Inc., which manufactures and markets Botaneco's proprietary product, Hydresia(TM), to personal care companies.

"These milestone payments demonstrate our progress with two key opportunities: safflower-produced insulin and the Botaneco business," said Andrew Baum, President and CEO of SemBioSys. "Our long-standing relationship with AVAC has provided access to non-dilutive capital allowing us to accelerate our progress on both our non-pharmaceutical and pharmaceutical products which have the potential to generate value in the both short- and longer-term, respectively. By achieving critical milestones we have continued to earn their support, specifically on the development of insulin and the commercialization of Hydresia(TM). We believe these two programs will be critical to our growth and we appreciate the commitment that AVAC has made to them."

SemBioSys received a $350,000 milestone payment for completing a number of technical objectives in the development of its insulin program, including the initiation of the preclinical toxicology study of the Company's safflower-produced insulin. The funds will be used to further develop and advance SemBioSys' insulin program and are part of up to $873,000 committed by AVAC. The Company intends to submit an
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. SemBioSys updates Apo AI development program
2. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
3. SemBioSys announces 2007 third quarter results
4. SemBioSys signs option agreement for safflower-produced food ingredient
5. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
6. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
7. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
8. SemBioSys announces 2007 financial and operational results
9. SemBioSys initiates toxicology study for safflower-produced insulin
10. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
11. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...A, Va., Nov. 9 CEL-SCI C... Dr. Kenneth S. Rosenthal, Professor of Immunology...s College of Medicine and Pharmacy, reported on wo...he Cleveland Clinic and CEL-SCI on CEL-SCI,s LEAPS...e 7th GTCbio Vaccine: "All Things Considered" Conf...
(Date:11/8/2009)...UNTAIN VIEW, Calif. Nov. 5, 2009 Complete Genomi...pany, today announced publication of a report in t...A sequencing platform, including analysis of seque...nsumables cost for these three genomes sequenced o...nged from $8,005 for 87x coverage to $1,726 for 45...
(Date:11/6/2009)...Y, Mass., Nov. 6 Myriant Technolog...eloper and manufacturer of renewable bio-chemical...echnology provider Uhde GmbH, one of the world,s l...nnounced an alliance for the engineering, procurem... Succinic Acid plants based on renewable feedstock...
(Date:11/6/2009)...RD, Calif., Nov. 6 Intarcia Therap...its ITCA 650 (DUROS® continuous delivery of e...etes at the Ninth Annual Diabetes Technology Meeti...newscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,...e Via ITCA 650 Lowers Plasma Glucose, HbA1c and Re...
Breaking Biology Technology:CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5
...d. NASA Goddard Space Flight Center in Greenbelt,...turing high-quality carbon nanotubes (CNT) has bee...fs Nano 50 awards in the Technology category. This...nner November 14 at the NASA Tech Briefs National ... Mass. , Judged by a panel of nanotechnology expe...
...change Symbol: MS, EDMONTON, Nov. 14 /PRNewswire-...ng developer in the treatment of multiple sclerosi...results for the third quarter, ended,September 30,...ain momentum towards the,commercialization of our ...sclerosis," said Kevin Giese, President and CEO of...
...., Nov. 14 MedPredict Market Research,a global pr...and market,research, has published a new report pr...biotech companies with a stake in the market for M... Thought Leader Insight & Analysis:,Multiple Scler...sies,emerging from ECTRIMS (European Committee for...
Other Biology Technology:NASA Goddard Space Flight Center's carbon nanotube manufacturing technology wins Nano 50 Award 2BioMS Medical announces third quarter 2007 results 2BioMS Medical announces third quarter 2007 results 3BioMS Medical announces third quarter 2007 results 4New Report Analyzes Key Controversies in Multiple Sclerosis Treatment 2
(Date:11/8/2009)...AYETTE, Ind. - Researchers at Purdue University ha... nerve fibers in spinal cord injuries using nano-s...ly after an accident. , The synthetic "copolymer...meters in diameter, or roughly 100 times smaller t...ers have been studying how to deliver drugs for ca...
(Date:11/6/2009)...ng ants generally live in harmony with their arbor...y run out of space in their trees of choice, the a...The research, published in the November issue of t... that ants bore into live trees, and it reopens a ...nts and plants. , Ants and certain species of pl...
(Date:11/5/2009)...University has been awarded a training grant in th...ndation under its Integrative Graduation Education...e first IGERT grant to be awarded to Kent State. T...ery and Reinvestment Act of 2009, runs through 201...es on environment aquatic resource sensing (EARS)....
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Ants are friendly to some trees, but not others 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Study identifies potential fix for damaged knees 51203 1Study identifies potential fix for damaged knees 51203 2Study identifies potential fix for damaged knees 51203 3European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 1European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 2ZyGEM Releases Data Confirming Its prepGEM 28R 29 Bacteria Kit Is a Simple Universal Method for Extracting DNA from Different Bacteria Species 51198 1ZyGEM Releases Data Confirming Its prepGEM 28R 29 Bacteria Kit Is a Simple Universal Method for Extracting DNA from Different Bacteria Species 51198 2ZyGEM Releases Data Confirming Its prepGEM 28R 29 Bacteria Kit Is a Simple Universal Method for Extracting DNA from Different Bacteria Species 51198 3ZyGEM Releases Data Confirming Its prepGEM 28R 29 Bacteria Kit Is a Simple Universal Method for Extracting DNA from Different Bacteria Species 51198 4
...USA - Topics include: discovery of Sudbury impact...ersal of early modern humans out of Africa; relati... relationship of San Andreas fault system activity...cations of sediment mixing in studying the Great B...oseismology addresses earthquake prediction. The G...
...a, August 28, 2007 A new poisonous frog was recent...lombia by a team of young scientists supported by ...ew frog, which is almost two centimetres in length... Originally, the young scientists thought the frog...e area. However, after scientific analysis of the ...
...ished in the September 2007 issue of the Journal ...IGHLIGHTS , , , Renal transplant recipients ge...n use, New skin-healing chemicals, New anti-in... Understanding how obese fat cells work, , , , ... does not negatively impact fluvastatin use , Sci...
Other Biology News:September Geology and GSA Today media highlights 2September Geology and GSA Today media highlights 3September Geology and GSA Today media highlights 4September Geology and GSA Today media highlights 5September Geology and GSA Today media highlights 6September Geology and GSA Today media highlights 7September Geology and GSA Today media highlights 8September Geology and GSA Today media highlights 9September Geology and GSA Today media highlights 10September Geology and GSA Today media highlights 11September Geology and GSA Today media highlights 12Story ideas from the Journal of Lipid Research 2Story ideas from the Journal of Lipid Research 3Story ideas from the Journal of Lipid Research 4Story ideas from the Journal of Lipid Research 5
AGAROSE II (LOW MELT) from Pierce Biotechnology, Inc.
...antibody raised against a partial recombinant FES.... partial recombinant protein with GST tag. Prot...KYQEASKDKDRDKAKDKYVRSLWKLFAHHNRYVLGVRAAQLHHQHHHQLL...Accession: BC035357 Protein Accession Number: ...
Mouse Anti-Human ACTN4 Monoclonal Antibody, Unconjugated, Clone 4D10 from Abnova Corporation
Mouse Anti-Human PDE2A Monoclonal Antibody, Unconjugated, Clone 4F4 from Abnova Corporation
Biology Products: